Products and Services

Biosimilars: Litigation and Portfolio Building Strategies (1General Credit) - Indy Store

ON-DEMAND ONLINE CLE COURSES (1000)
Biosimilars: Litigation and Portfolio Building Strategies (1General Credit)

Date: 12/16/2020

Credit Hour(s)
General Credit – 1 Hour
Ethics Credit – 0 Hour
CME Credit - 0 Hour
NLS Credit –  0 Hour

Continuing Legal Education

Biological pharmaceuticals are a growth market. At this seminar, our speakers will provide an update on 2020 biologics patent litigation and explore what the results mean for designing and implementing a patent strategy for a biological product. We'll also discuss how to use the pharma-specific tools like patent term extensions to plan your patenting timeline to best protect your inventors’ discoveries and avoid common prosecution pitfalls.

PLEASE NOTE: Once you review the program in its entirety, the IndyBar will report all credits earned within 10 days of completion directly to the Indiana Commission for Continuing Legal Education.  Posting by the Indiana CLE Commission of the credit to your CLE transcript may take 30 days. Additionally, there are codes provided to the live audience during this webinar to verify attendance.  Those viewing this recording do not need to report those codes.

Featuring
David Berl, Williams and Connolly LLP; Christine Hansen, Quarles & Brady LLP

 



DID YOU KNOW?

Indianapolis Bar Association (IndyBar) est. 1878 | 4,536 Members (as of 2.11.21)